Good Afternoon. On July 6, 1885 — 141 years ago today — Louis Pasteur injected a 9-year-old boy named Joseph Meister with the world's first rabies vaccine, saving his life and, incidentally, giving us the modern concept that a shock to the system can be treated.

Today's session was the recovery — the Nasdaq clawed back a healthy chunk of Thursday's damage, chip stocks stopped bleeding, and traders remembered they've got FOMC minutes Wednesday and Q2 earnings starting Thursday. Not everything's fixed, but the panic's been vaccinated.

—Rosie, Wyatt, Evan & Conor

🔥 What’s Hot: 🔥

🥶 What’s Not: 🥶

🔢 Big number: $4,163 — where Comex gold futures settled today, another fresh record and up roughly 4% in a week, as a softer dollar and reset Fed path keep the debasement trade humming.

1. Tech finds its feet

The news: After Thursday's ugly semi wipeout, U.S. equities came back swinging Monday. The Nasdaq 100 jumped 1.54%, the S&P 500 added 0.95%, and the VIX dropped to 20.65 as traders decided the AI-capex de-rating didn't need a sequel. Mega-cap names did the heavy lifting: Meta +3.02%, Tesla +5.71%, Alphabet +1.86%, Amazon +1.11%, and even Apple tacked on another 1.46%. The session got a Sunday assist from Foxconn, which reported stronger-than-expected Q2 sales driven by AI-server demand — the world's biggest iPhone and Nvidia-server assembler basically told the market that hyperscaler orders haven't slowed.

Big picture: One green session doesn't undo three weeks of chip-equipment carnage — AMAT still finished today -1.23% and hasn't recovered its footing — but it does suggest the market's finally distinguishing between "AI capex has peaked" and "AI capex has paused." Software and platforms (META, GOOGL, MSFT ecosystem) can grow into their multiples even if chip suppliers face a customer digestion phase. If Q2 earnings from Delta and PepsiCo on Thursday deliver clean numbers, the bounce has legs. If not, we're back to arguing whether an S&P forward P/E at 22.5x deserves the benefit of the doubt.

Source: Yahoo Finance / TheStreet / WSJ

2. Fed minutes and earnings loom

The news: The calendar's about to get spicy. FOMC minutes from the June 17-18 meeting land Wednesday, July 8 — the first look inside the committee's head before Thursday's jobs miss reshaped expectations. Q2 earnings season kicks off Thursday, July 9 with Delta Air Lines and PepsiCo, followed by the mega-banks the next week (JPMorgan, Wells Fargo, Citi all report July 14). CME Fed-funds futures now put July hike odds at 24%, down from 30% a week ago and 45% ten days ago; the market is pricing in two full cuts by year-end.

What's next: Wednesday's minutes need to show at least a couple of members already leaning dovish pre-jobs — otherwise the two-cut narrative starts feeling premature. Delta's numbers will tell you what the consumer is actually doing (business travel, premium cabin mix), and Pepsi's guide will show whether food inflation has finally cooled enough to help volumes. Then it's bank week, where net interest margin commentary and credit-loss reserves will decide whether the sector's ~20% YTD run is a proper cycle trade or a rate-cut sugar high.

Source: Livemint / U.S. News — payrolls to profits

3. Apple's iPhone gets a fatter lineup

The news: Apple shares added 1.46% Monday, extending Thursday's post-Bloomberg pop, on continued digestion of a Mark Gurman report that says Cupertino will refresh the iPhone lineup to five models this September — adding a slimmer "iPhone Air" between the standard and Pro variants. It's the biggest structural change to the flagship since the Plus line launched in 2022, and Wall Street is treating it like a fresh product-cycle upgrade catalyst into what would otherwise be a sleepy back-to-school setup.

Bottom line: Apple's stock has been an oddball this year — up but not spectacular, dragged by services growth deceleration and antitrust noise. A wider iPhone lineup gives the sales team more ASP flexibility (a mid-tier premium Air can shift customers up from the base and down from the Pro Max), and services benefit from any incremental hardware install base. It's not a magic bullet for a $3.5 trillion company, but at these multiples every mid-single-digit unit tailwind matters.

Source: Yahoo Finance company news

4. SpaceX joins the club

The news: SpaceX — Elon Musk's rocket-and-satellite giant — will officially be added to the Nasdaq 100 index tomorrow, Tuesday, July 7, replacing Warner Bros. Discovery in the reshuffle. The index change was pre-announced last month, but the passive-flow demand hits at Tuesday's close, and index-tracking ETFs (QQQ chief among them) will need to buy an estimated $14-16 billion worth of SpaceX shares. It's the biggest single-name index addition since Tesla joined the S&P 500 in December 2020.

What's next: The mechanical demand heading into tomorrow's close is a known unknown — dealers have been positioning for weeks — but the second-order story is what happens to launch cadence, Starlink pricing, and Starshield defense contracts now that SpaceX has to answer to public shareholders. Expect a much more disciplined disclosure rhythm from a company that has historically dropped news via Musk's X account at midnight. Sector-wise, defense contractors and legacy satellite operators (Boeing, Lockheed, Iridium) will feel more competitive pressure as SpaceX's new-found capital access widens.

Source: WSJ live coverage

5. AeroVironment lands a half-billion

The news: AeroVironment shares rocketed 10.7% Monday after the Arlington, Virginia-based drone maker disclosed a $500 million ceiling contract from the U.S. Army for its Switchblade loitering munitions — the same tube-launched suicide drones that have been in heavy demand from Ukraine and Taiwan defense procurement. The award is a five-year indefinite-delivery vehicle, meaning AeroVironment competes for individual task orders, but Wall Street's already modeling ~$100M/year in incremental revenue against a company that did $832 million in fiscal 2026 sales.

Bottom line: Defense-tech is the sneaky bull market of 2026 — AVAV +67% YTD, Palantir +42%, Anduril's IPO rumored for Q4 — and this contract validates the thesis that legacy primes are losing share to smaller, faster, software-first competitors. If you own XAR or ITA (the two big defense ETFs), you're already exposed. If you don't, this is a reminder that a Pentagon budget that keeps growing faster than S&P 500 earnings is a durable multi-year tailwind.

Source: Yahoo Finance company news

6. OPEC+ turns up the tap again

The news: OPEC+ eight — Saudi Arabia, Russia, and six co-conspirators — confirmed Sunday that they'll add another +188,000 barrels per day to August production, matching the June and July increments and locking in the fourth straight monthly increase. Brent fell about 1% to $71.72 in response — mildly weaker but not a rout, since the hike was widely telegraphed. Meanwhile, Strait of Hormuz exports have fully recovered from June's brief wartime disruption, and Saudi shipping insurance premiums have dropped back to pre-conflict levels.

Big picture: The group has now formally unwound roughly 1.4 million bpd of the 2.2 million bpd of voluntary cuts it announced last year, and the pace suggests full unwind by Q1 2027. For consumers, that's slowly working its way into cheaper gasoline (U.S. retail average $3.18/gal, down 11 cents in a month) and softer CPI energy readings. For producers, it's a game of chicken with U.S. shale, which has held flat around 13.4 million bpd all year and needs Brent above $65 to add rigs. If OPEC+ pushes prices into the $60s, U.S. supply growth stalls and the group reclaims share. That's the whole strategy in one sentence.

Source: NY Post / Reuters commentary / Al Jazeera

7. SK Hynix's $28B US listing

The news: SK Hynix — the Korean memory-chip powerhouse that supplies roughly half of the world's high-bandwidth memory (HBM) for AI servers — is finalizing a secondary U.S. listing worth up to $28 billion, according to weekend reporting from Bloomberg and Korean outlets. If it prices at the upper end, it would be the largest first-time share sale by a foreign company ever on U.S. markets. The banks running the book are targeting a late-July or early-August launch, and Samsung Electronics reports preliminary Q2 earnings Tuesday morning, which will set the tone for the whole HBM group.

What's next: A Hynix U.S. listing gives American funds direct access to the single-most-critical AI supply-chain name outside Nvidia — HBM is the reason a Blackwell GPU works — and it would arrive with a valuation of roughly $180 billion, larger than Micron's current $153B market cap. If Samsung guides Q2 memory revenue above street consensus Tuesday, the whole memory-chip sector gets a re-rating just as the Hynix roadshow starts. If it disappoints, Hynix bankers will be doing a lot of hand-holding in the coming three weeks. The Kospi finished today -0.5%, waiting to see.

Source: Bloomberg TV

8. Hedge funds keep dumping chips

The news: A weekend Goldman Sachs prime brokerage note to clients revealed that hedge funds sold info-tech stocks for a fourth consecutive week, making it the most net-sold sector on Goldman's book. Semis were the epicenter — the Philadelphia Semiconductor Index (SOX) fell 4.2% last week and is down 9.8% in a month, cutting deep into hedge-fund books that spent all of 2025 loaded up on the AI trade. Long/short funds ended June with net exposure to tech at the lowest since October 2024.

Bottom line: When hedge funds get out en masse, two things typically happen: the sector overshoots to the downside as forced selling exhausts, and then contrarian long-only money starts nibbling once the sell-side upgrades start rolling. We might be in the first phase. Watch Nvidia heading into its August 27 earnings — if guidance holds up, this whole four-week de-grossing gets reversed in a hurry as funds scramble to rebuild exposure. If it doesn't, the SOX has another 10-15% downside before valuations look interesting.

Source: Reuters via U.S. News

Q: What do you call a deer with no eyes?

A: Noideer

Regression to the Mean is the statistical tendency for extreme outcomes — great or terrible — to drift back toward the long-run average over time. Named by Francis Galton in 1886 after he noticed that unusually tall parents had children who were tall but slightly less so, it now shows up everywhere in investing: last quarter's best-performing sector rarely repeats, and last week's worst-hit trade often bounces harder than the broad market.

Why now? Because today's session was regression to the mean in living color. Last week the Philadelphia Semi Index fell nearly 10% in eight sessions — a two-standard-deviation move. Today it added back ~2% as the extreme sellers ran out of shares to dump and mean-reverting funds started nibbling. It's not a call that chips are cheap forever — it's just math: when a group moves that far that fast, the odds of a partial reversal go up.

The same logic works the other way: gold has now had a 41% year and is up 70% over 24 months. That doesn't mean it's about to collapse, but statistically it's a lot easier for gold's next 12 months to underperform its trailing 24. Investors who mistake regression for a permanent trend reversal typically get whipsawed. The trick is to size positions assuming that streaks — good or bad — eventually normalize, and to distinguish between mean-reversion

Stay Ahead of an Emerging Industry

Psychedelics are moving from the fringe into serious conversations around medicine, mental health, culture, and investing. The Drop In by DoubleBlind helps you stay informed with the latest psychedelic research, cultural insights, and transformative personal stories — trusted by more than 130,000 readers. Delivered every Monday and Thursday, it’s an easy way to keep an eye on one of the most fascinating and fast-evolving industries today. Sign-up here.